Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: Relationship to muscle size and function

Journal of Applied Physiology

Volumn 110, Issue 4, 2011, Pages 892-900

  Toth, Michael J ^a   Ward, Kimberly ^a   Van Der Velden, Jos ^a   Miller, Mark S ^a   VanBuren, Peter ^a   LeWinter, Martin M ^a   Ades, Philip A ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Atrophy; Cachexia; Myosin; Sarcopenia

Indexed keywords

EIF4EBP1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PHOSPHOPROTEIN; PROTEIN KINASE B; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SOMATOMEDIN C; TARGET OF RAPAMYCIN KINASE;

ARTICLE; BODY COMPOSITION; FEMALE; HEART FAILURE; HUMAN; MALE; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TORQUE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; BODY COMPOSITION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HEART FAILURE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TORQUE;

EID: 79954607087     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00545.2010     Document Type: Article

References (60)

1. Ades PA, Savage PD, Brochu M, Tischler MD, Lee NM, Poehlman ET. Resistance training increases total daily energy expenditure in disabled older women with coronary disease. J Appl Physiol 98: 1280-1285, 2005. (Pubitemid 40396501)
2. Ades PA, Savage PD, Cress ME, Brochu M, Lee NM, Poehlman ET. Resistance training on physical performance in disabled older female cardiac patients. Med Sci Sports Exerc 35: 1265-1270, 2003. (Pubitemid 36936142)
3. Alesi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551, 1996. (Pubitemid 26413787)
4. Bean JF, Kiely DK, Herman S, Leveille SG, Mizer K, Frontera WR, Fielding RA. The relationship between leg power and physical performance in mobility limited elders. J Am Geriatr Soc 50: 461-467, 2002. (Pubitemid 34229401)
5. Bentzinger CF, Romanino K, Cloëtta D, Lin S, Mascarenhas JB, Oliveri F, Xia J, Casanova E, Costa CF, Brink M, Zorzato F, Hall MN, Rüegg MA. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metabolism 8: 411-424, 2008.
6. Blaauw B, Canato M, Agatea L, Toniolo L, Mammucari C, Masiero E, Abraham R, Sandri M, Schiaffino S, Reggiani C. Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation. FASEB J 23: 3896-3905, 2009.
7. Brozinick JT, Roberts BR, Dohm GL. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle. Diabetes 52: 935-941, 2003. (Pubitemid 36384263)
8. Cheng SWY, Fryer LGD, Carling D, Shepherd PR. Thr2446 Is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem 279: 15719-15722, 2004. (Pubitemid 38509255)
9. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995. (Pubitemid 26004411)
10. Dalla Libera L, Ravara B, Volterrani M, Gobbo V, Barbera MD, Angelini A, Betto DD, Germinario E, Vescovo G. Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol 286: C138-C144, 2004. (Pubitemid 38055822)
11. D'Antona G, Pellegrino MA, Adami R, Rossi R, Carlizzi CN, Canepari M, Saltin B, Bottinelli R. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol 552: 499-511, 2003. (Pubitemid 37321847)
12. Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR, Caron MA, LeBlanc P, Maltais F. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176: 261-269, 2007. (Pubitemid 47195876)
13. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63: 645-651, 1981. (Pubitemid 11139875)
14. Fiatarone-Singh MA, Ding W, Manfredi TJ, Solares GS, O'Neil EF, Clements KM, Ryan ND, Kehayias JJ, Fielding RA, Evans WJ. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Physiol Endocrinol Metab 277: E135-E143, 1999. (Pubitemid 29356737)
15. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/ eIF4E. Genes Dev 16: 1472-1487, 2002. (Pubitemid 34686329)
16. Frost RA, Lang CH. Protein kinase B/Akt: A nexus of growth and cytokine signaling in determining muscle mass. J Appl Physiol 103: 378-387, 2007. (Pubitemid 47092315)
17. Geiger PC, Cody MJ, Macken RL, Sieck GC. Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers. J Appl Physiol 89: 695-703, 2000. (Pubitemid 30637120)
18. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 Is required for signaling to Akt-FOXO and PKC[alpha], but not S6K1. Dev Cell 11: 859-871, 2006. (Pubitemid 44804279)
19. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of Raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226, 2008. (Pubitemid 351626684)
20. Hambrecht R, Schulze PC, Gielen S, Linke A, Mobius-Winkler S, Yu J, Kratzsch J, Baldauf G, Musse MW, Schubert A, Adams V, Schuler G. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol 39: 1175-1181, 2002. (Pubitemid 34267422)
21. Hameed M, Lange KHW, Anderson JL, Schjerling P, Kjaer M, Harridge SDR, Goldspink G. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 555: 231-240, 2004. (Pubitemid 38313073)
22. Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SDR. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol 547: 247-254, 2003. (Pubitemid 36285178)
23. Harrington D, Coats AJ. Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure. Eur Heart J 18: 1865-1872, 1997. (Pubitemid 27526116)
24. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345: 1223-1229, 2001. (Pubitemid 34951485)
25. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, Pierson RN. Appendicular skeletal muscle mass: Measurement by dualphoton absorptiometry. Am J Clin Nutr 52: 214-218, 1990.
26. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127: 125-137, 2006. (Pubitemid 44466632)
27. Kemppainen J, Tsuchida H, Stolen K, Karlsson H, Bjonholm M, Heinonen OJ, Nuutila P, Krook A, Knuuti J, Zierath JR. Insulin signalling and resistance in patients with chronic heart failure. J Physiol 550: 305-315, 2003. (Pubitemid 36869289)
28. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104: 733-741, 1999. (Pubitemid 29536358)
29. Lai KV, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AR, Yancopoulos GD, Glass DJ. Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24: 9295-9304, 2004. (Pubitemid 39391668)
30. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP. Akt signaling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 576: 923-933, 2006. (Pubitemid 44637894)
31. Leger B, Derave W, De Bock K, Hespel P, Russell AP. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuv Res 11: 163-175B, 2008.
32. Leger B, Senese R, Al-Khodairy AW, Deriaz O, Gobelet C, Giacobino JP, Russell AP. Atrogin-1, MuRF-1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 40: 69-78, 2009.
33. Leger B, Vergani L, Soraru G, Hespel P, Gobelet C, D'Ascenzio C, Angelini C, Russell AP. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20: 583-585, 2006. (Pubitemid 46671257)
34. Lunde PK, Sejersted OM, Thorud HMS, Tonnessen T, Henriksen UL, Christensen G, Westerblad H, Bruton J. Effects of congestive heart failure on Ca2 handling in skeletal muscle during fatigue. Circ Res 98: 1514-1519, 2006. (Pubitemid 44297074)
35. Lynch CJ, Patson BJ, Anthony JM, Vaval A, Jefferson LS, Vary TC. Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue. Am J Physiol Endocrinol Metab 283: E503-E513, 2002. (Pubitemid 35230488)
36. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83: 778-786, 1991.
37. Manning BD, Cantley LC. AKT/PKB signaling: Navigating downstream. Cell 129: 1261-1274, 2007. (Pubitemid 46962095)
38. Miller MS, VanBuren P, LeWinter MM, Braddock JM, Ades PA, Maughan DW, Palmer BM, Toth MJ. Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibers from humans. J Physiol 588: 4039-4053, 2010.
39. Miller MS, VanBuren P, LeWinter MM, Lecker SH, Selby DE, Palmer BM, Maughan DW, Ades PA, Toth MJ. Mechanisms underlying skeletal muscle weakness in human heart failure: Alterations in single fiber myosin protein content and function. Circ: Heart Fail 2: 700-706, 2009.
40. Nader GA. Molecular determinants of skeletal muscle mass: Getting the "AKT" together. Int J Biochem Cell Biol 37: 1985-1996, 2005. (Pubitemid 41206816)
41. Neibauer J, Pflaum CD, Clar AL, Strasburger CJ, Hooper J, Poole- Wilson PA, Coats AJS, Anker SD. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohumoral activation. J Am Coll Cardiol 32: 393-397, 1998. (Pubitemid 28396488)
42. Neill WA, Branch LG, DeJong G. Cardiac disability-the impact of coronary disease on patients' daily activities. Arch Intern Med 145: 1642-1647, 1985. (Pubitemid 16258206)
43. Pinsky JL, Jette AM, Branch LG, Kannel WB, Feinleib M. The Framingham Disability Study: Relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am J Public Health 80: 1363-1368, 1990. (Pubitemid 20375556)
44. Ploutz-Snyder LL, Manini T, Ploutz-Snyder RJ, Wolf DA. Functionally relevant thresholds of quadriceps femoris strength. J Gerontol 57: B144-B152, 2002. (Pubitemid 34263291)
45. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biol 3: 1009-1013, 2001. (Pubitemid 34428746)
46. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 177: 399-412, 2004. (Pubitemid 38534545)
47. Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res 97: 418-426, 2005. (Pubitemid 41298171)
48. Schulze PC, Gielen S, Adams V, Linde A, Mobius-Winkler S, Erbs S, Kratzsch J, Hambrecht R, Schuler G. Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulin-like growth factor-I in chronic heart failure. Basic Res Cardiol 98: 267-274, 2003. (Pubitemid 36874026)
49. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, Zierath JR. Muscle fiber type specificity in insulin signal transduction. Am J Physiol Regul Integr Comp Physiol 277: R1690-R1696, 1999. (Pubitemid 30043776)
50. Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115: 451-458, 2005. (Pubitemid 40385487)
51. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004. (Pubitemid 38591410)
52. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC, Coats AJS. Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure. J Am Coll Cardiol 30: 527-532, 1997. (Pubitemid 27339335)
53. Toth MJ, Ades PA, LeWinter MM, Tracy RP, Tchernof A. Skeletal muscle myofibrillar mRNA expression in heart failure: Relationship to local and circulating hormones. J Appl Physiol 100: 35-41, 2006. (Pubitemid 43671087)
54. Toth MJ, Goran MI, Ades PA, Howard DB, Poehlman ET. Examination of data normalization procedures for expressing peak VO2 data. J Appl Physiol 75: 2288-2292, 1993. (Pubitemid 23352407)
55. Toth MJ, Gottlieb SS, Goran MI, Fisher ML, Poehlman ET. Daily energy expenditure in free-living heart failure patients. Am J Physiol Endocrinol Metab 272: E469-E475, 1997.
56. Toth MJ, Matthews DE, Ades PA, Tischler MD, VanBuren P, Previs M, LeWinter MM. Skeletal muscle myofibrillar protein metabolism in heart failure: Relationship to immune activation and functional capacity. Am J Physiol Endocrinol Metab 288: E685-E692, 2005. (Pubitemid 40397202)
57. Toth MJ, Shaw AO, Miller MS, VanBuren P, LeWinter MM, Maughan D, Ades PA. Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol 143: 276-282, 2010.
58. van Hees HWH, van der Heijden HFM, Ottenheijm CAC, Heunks LMA, Pigmans CJC, Verheugt FWA, Brouwer RMHJ, Dekhuijzen PNR. Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats. Am J Physiol Heart Circ Physiol 293: H819-H828, 2007. (Pubitemid 47105147)
59. Welsh GI, Miller CM, Loughlin AJ, Price NT, Proud CG. Regulation of eukaryotic intiation factor eIF2B: Glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett 421: 125-130, 1998. (Pubitemid 28288076)
60. Yates LD, Greaser ML. Quantitative determination of myosin and actin in rabbit skeletal muscle. J Mol Biol 168: 123-141, 1983.